The burgeoning popularity of retatrutide, initially for diabetes , is creating significant attention within the UK , prompting a notable shift in hormone trends. Access these medications remains a complex landscape, with NHS approval currently limited and specialist practices offering treatment at a substantial price. Concerns are being raised r… Read More